As the United States ramps up efforts to clear homeless encampments from city streets, more states are turning to a tool researchers have spent decades scrutinising: involuntary drug treatment. A July 2025 executive order from President Donald Trump and a wave of new state laws have pushed compulsory substance use treatment to the centre of American drug policy. But as this expansion accelerates, serious questions about how it works in practice are surfacing across the country.

Federal Authority Drives Involuntary Drug Treatment Forward

President Trump signed the executive order on 24 July 2025. It directed federal agencies to support civil commitment for homeless individuals living with mental illness or addiction. The order called on the Attorney General and the Secretary of Health and Human Services to push states toward “maximally flexible” civil commitment standards. It also told agencies to prioritise federal grants for municipalities that enforce anti-camping laws and move people into treatment facilities.

The order pointed to stark figures. On a single night in the final year of the previous administration, 274,224 people slept rough across the United States. That was the highest number ever recorded. The order noted that addiction, mental illness, or both affected the vast majority of those individuals. It framed involuntary treatment as a humane alternative to leaving vulnerable people without structured care.

The ripple effects came quickly. In September 2025, Utah officials revealed plans for a 16-acre facility outside Salt Lake City. It would hold up to 1,300 people cleared from public spaces. Those people would face a choice: enter an abstinence-based shelter or face jail. Officials set aside 300 to 400 beds for compulsory substance use treatment for adults with psychiatric and drug-related conditions. New Jersey, Washington State and New York have since floated similar proposals.

What the Research Record Shows About Compulsory Substance Use Treatment

Three major systematic reviews, published in 2005, 2016 and 2023, have examined the evidence on coercive addiction treatment in adults. Researchers studied a wide range of coercive approaches. Their findings point to one consistent challenge: outcomes from civil commitment depend heavily on what happens inside the facility and what support exists after release.

Studies focused on true involuntary civil commitment show limited measurable benefit under current programme designs. Researchers most commonly flag higher rates of relapse and rearrest following release. They link these outcomes to weak aftercare and poor transition planning.

One international study found that the risk of death rises sharply in the weeks after someone leaves involuntary drug treatment. Overdose was the leading cause. Enforced abstinence lowers a person’s drug tolerance. Without continued structured support after release, a return to previous use can be fatal.

Massachusetts data tells a similar story. Adults with a history of compulsory substance use treatment faced a 40% higher risk of death from overdose than those who had never undergone such treatment. That figure highlights how much the period after commitment matters.

Why Aftercare Defines Involuntary Drug Treatment Outcomes

Experts point out that involuntary drug treatment tends to fall short not because structured intervention is the wrong idea. It falls short because the exit from it is poorly managed. Abrupt discharge, no recovery plan, weak follow-up care and limited connection to ongoing abstinence support all undermine results.

The executive order addressed this directly. It directed the Attorney General to strengthen requirements for release planning in detention facilities. Officials must now ensure that individuals leave with structured plans in place. The order also pushed for more drug courts and mental health courts. These provide structured oversight and accountability throughout recovery.

By early 2026, 37 states and the District of Columbia had laws allowing involuntary treatment for substance use disorder. Most had expanded or introduced new civil commitment statutes within the past decade. Yet reporting remains inconsistent. Only Massachusetts and Washington have published formal outcome evaluations of their programmes. Washington’s programme has been running for eight years and has produced just one such evaluation. Policymakers need more data, more often, if these programmes are going to improve.

Building a Framework That Works

The scale of what the United States is now attempting is significant. Roughly two-thirds of homeless individuals report having used hard drugs such as methamphetamine, cocaine or opioids during their lifetime. An equally large share report mental health conditions. Addressing both through compulsory substance use treatment at scale will require well-designed facilities, trained staff and strong post-release structures.

The executive order pointed toward this. It emphasised shifting individuals into private housing and support networks, with continued access to mental health and substance use services. Drug courts, mental health courts and mandatory release planning form part of that picture.

Prevention carries the greatest long-term impact. Reaching people before dependency develops, through education, early intervention and clear messaging about the dangers of drug use, reduces the number of people who eventually need intensive treatment. The financial case is straightforward too. Prevention costs a fraction of institutional care. The social returns stretch across families and communities for generations.

Compulsory substance use treatment marks a real shift in how America tackles visible drug dependency and homelessness. Its success will not rest on commitment alone. It will rest on the quality of care provided, the strength of the support that follows and the commitment to keeping people from reaching crisis point in the first place.

Source: dbrecoveryresources